Want to see APNHY full AI Analyst Report?
Total Valuation
Aspen Pharmacare has a market cap or net worth of $4.15B. The enterprise value is $4.78K.
Market Cap$4.15B
Enterprise Value$4.78K
Share Statistics
Aspen Pharmacare has 432,921,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding432,921,450
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aspen Pharmacare’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 5.43%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)5.43%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee3.57M
Profits Per Employee-90.98K
Employee Count9,557
Asset Turnover0.32
Inventory Turnover1.47
Valuation Ratios
The current PE Ratio of Aspen Pharmacare is 26.3. Aspen Pharmacare’s PEG ratio is -0.08.
PE Ratio26.3
PS Ratio2.00
PB Ratio0.86
Price to Fair Value0.86
Price to FCF14.78
Price to Operating Cash Flow10.14
PEG Ratio-0.08
Income Statement
In the last 12 months, Aspen Pharmacare had revenue of 34.14B and earned 2.59B in profits. Earnings per share was 5.79.
Revenue34.14B
Gross Profit13.76B
Operating Income5.29B
Pretax Income-409.30M
Net Income2.59B
EBITDA7.16B
Earnings Per Share (EPS)5.79
Cash Flow
In the last 12 months, operating cash flow was 7.02B and capital expenditures -2.19B, giving a free cash flow of 4.83B billion.
Operating Cash Flow7.02B
Free Cash Flow4.83B
Free Cash Flow per Share11.16
Dividends & Yields
Aspen Pharmacare pays an annual dividend of $0.144, resulting in a dividend yield of 1.27%
Dividend Per Share$0.144
Dividend Yield1.27%
Payout Ratio34.64%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change76.59%
50-Day Moving Average9.31
200-Day Moving Average8.27
Relative Strength Index (RSI)51.16
Average Volume (3m)37.00
Important Dates
Aspen Pharmacare upcoming earnings date is Mar 11, 2027, TBA (Confirmed).
Last Earnings DateSep 2, 2026
Next Earnings DateMar 11, 2027
Ex-Dividend Date―
Financial Position
Aspen Pharmacare as a current ratio of 2.54, with Debt / Equity ratio of 19.37%
Current Ratio2.54
Quick Ratio1.68
Debt to Market Cap0.23
Net Debt to EBITDA-0.06
Interest Coverage Ratio3.51
Taxes
In the past 12 months, Aspen Pharmacare has paid 460.22M in taxes.
Income Tax460.22M
Effective Tax Rate-1.12
Enterprise Valuation
Aspen Pharmacare EV to EBITDA ratio is 9.49, with an EV/FCF ratio of 14.69.
EV to Sales1.99
EV to EBITDA9.49
EV to Free Cash Flow14.69
EV to Operating Cash Flow10.11
Balance Sheet
Aspen Pharmacare has $15.87B in cash and marketable securities with $15.44B in debt, giving a net cash position of $425.58M billion.
Cash & Marketable Securities$15.87B
Total Debt$15.44B
Net Cash$425.58M
Net Cash Per Share$0.98
Tangible Book Value Per Share$82.60
Margins
Gross margin is 40.31%, with operating margin of 15.48%, and net profit margin of 7.59%.
Gross Margin40.31%
Operating Margin15.48%
Pretax Margin-1.20%
Net Profit Margin7.59%
EBITDA Margin20.98%
EBIT Margin15.48%
Analyst Forecast
The average price target for Aspen Pharmacare is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.45%
EPS Growth Forecast―